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Abstract
Background: Gorlin-Goltz syndrome, also known as nevoid basal cell carcinoma syndrome, is a rare genetic disorder
that is transmitted in an autosomal dominant manner with complete penetrance and variable expressivity. It is
caused in 85% of the cases with a known etiology by pathogenic variants in the PTCH1 gene, and is characterized
by a wide range of developmental abnormalities and a predisposition to multiple neoplasms. The manifestations
are multiple and systemic and consist of basal cell carcinomas in various regions, odontogenic keratocistic tumors
and skeletal anomalies, to name the most frequent. Despite the scarce medical literature on the topic, ocular
involvement in this syndrome is frequent and at the level of various ocular structures. Our study focuses on the
visual apparatus and its annexes in subjects with this syndrome, in order to better understand how this syndrome
affects the ocular system, and to evaluate with greater accuracy and precision the nature of these manifestations in
this group of patients.
Results: Our study confirms the presence of the commonly cited ocular findings in the general literature regarding
the syndrome [hypertelorism (45.5%), congenital cataract (18%), nystagmus (9%), colobomas (9%)] and highlights
strabismus (63% of the patients), epiretinal membranes (36%) and myelinated optic nerve fiber layers (36%) as the
most frequent ophthalmological findings in this group of patients.
Conclusions: The presence of characteristic and frequent ocular signs in the Gorlin- Goltz syndrome could help
with the diagnostic process in subjects suspected of having the syndrome who do not yet have a diagnosis. The
ophthalmologist has a role as part of a multidisciplinary team in managing these patients. The ophthalmological
follow-up that these patients require, can allow, if necessary, a timely therapy that could improve the visual
prognosis of such patients.
Keywords: Gorlin-Goltz syndrome, Gorlin syndrome, Nevoid basal cell carcinoma syndrome, Odontogenic keratocyst,
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Background
The Gorlin-Goltz syndrome (GGS), also termed nevoid
basal cell carcinoma syndrome (NBCCS), is a rare condi-
tion with estimated prevalence that ranges between 1/
30827 and 1/256,000 [1–5]. The disease affects both
men and women in rather equal manner [4] and is
characterized by a near complete penetrance with vari-
able expressivity [6]. It is inherited in an autosomal
dominant manner and is caused in about 50–85% of the
cases with a known etiology by pathogenic variants in
the tumor suppressor gene PTCH1 [7], located on
chromosome 9 (9q22.3) [1]. In 15–27% of the cases the
cause is still unknown [7, 8]. PTCH1 encodes for a
transmembrane receptor which recognizes sonic hedge-
hog signaling proteins [9]. The Hedgehog cell–cell sig-
naling pathway is crucial for embryogenesis and cell
division and its misregulation is implicated in numerous
birth defects and cancers. In unstimulated cells, pathway
activity is inhibited by the tumor suppressor membrane
protein, Patched. Hedgehog signaling is triggered by the
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secreted Hedgehog ligand, which binds and inhibits
Patched, thus setting in motion the downstream events
in signal transduction [10–14]. Homozygous inactivation
of the PTCH gene leads to tumorigenesis and the forma-
tion of multiple Basal Cell Carcinomas (BCCs) and other
neoplasms [15]. A two-hit model for developmental de-
fects in patients with Gorlin-Goltz syndrome has also
been suggested, according to that model subjects inherit
one defective copy of the tumor suppressor gene and ac-
quire a “second hit” mutation, such as from ultraviolet
light or ionizing radiation [16]. Recently, mutations in
suppressor of fused gene (SUFU) on chromosome 10q
and PTCH2 on chromosome 1p have been found in pa-
tients meeting criteria for Gorlin-Goltz syndrome [17,
18]. Of note, patients with SUFU mutations have an in-
creased risk of developing medulloblastoma as compared
to PTCH1 mutations in Gorlin-Goltz syndrome [6]. De
novo mutations represent approximately 20 to 30% of
cases [6, 19].
The syndrome has a wide range of manifestations [20–
22]. Multiple BCCs are the hallmark feature of Gorlin-
Goltz syndrome. Patients can present as early as infancy
with BCCs; however, the median age of development is
25 years [23]. the carcinomas may present as classic
translucent papules with telangiectasias or may resemble
acrochordons (skin tags) [23, 24]. Ovarian and cardiac fi-
bromas (25 and 3% respectively) are also a feature of the
syndrome [25].
Major criteria for diagnosis include: multiple (> 2)
BCCs or 1 BCC by ≤20 years of age, odontogenic kerato-
cysts of the jaw proven by histology, palmar or plantar
pitting, bilamellar calcification of the falx cerebri, bifid/
fused/splayed ribs, first-degree relative with NBCCS.
Minor criteria for the diagnosis of the syndrome in-
clude: medulloblastoma, increased circumference of the
head, congenital malformations (frontal bossing, coarse
facies, cleft lip/palate, moderate or severe hypertelor-
ism), other skeletal abnormalities (Sprengel deformity,
pectus deformities, syndactyly of the digits), radiologic
abnormalities (bridging of the sella turcica, hemiverteb-
rae, fusion or elongation of the vertebral bodies, model-
ing defects of the hands and feet, or flame-shaped
lucencies of the hands or feet), ovarian and cardiac fi-
bromas [20, 23].
Diagnosis of NBCCS requires the presence of two
major diagnostic criteria and one minor diagnostic cri-
terion or one major and three minor diagnostic criteria
[20, 23], Nonetheless, in most developed countries sub-
jects suspected of having the syndrome are getting gen-
etic testing done in search for PTCH1 mutations as a
final confirmation of the diagnosis.
Given that the syndrome has over 100 clinical mani-
festations and affects many major organ systems, most
studies of the Gorlin-Goltz syndrome in the medical
literature describe the systemic findings of the syndrome
and among those list some ocular manifestations [4, 20].
An article published in 2003 by Graeme C.M. Black
et al. studying ocular abnormalities in a series of 30
subjects diagnosed with Gorlin-Goltz syndrome
highlighted the vitreoretinal pathologies in this group
of patients [26].
Other Articles that deal specifically with the ophthal-
mological findings are confined to single patient case re-
ports of patients presenting ocular manifestations
(hypertelorism, congenital cataract, glaucoma, strabis-
mus, myelinated fibers of the optic nerve, macular
pucker, retinal holes, retinal hamartoma and different
types of colobomas [4, 15, 24, 25, 27–32]).
This is the first study in which 11 confirmed Gorlin-
Goltz patients went through a complete and comprehen-
sive ophthalmologic and orthoptic exams.
Materials and methods
An observational, cross sectional study was carried out
on 11 consecutive patients (7 females and 4 males) with
a mean age of 38.5 years (ages range from 18 to 74
years), with previous diagnosis of Gorlin-Goltz syndrome
according to the diagnostic criteria of Kimonis (1997),
confirmed molecularly with genetic testing, which re-
sulted in 100% of our patients showing a pathogenic
variant in the PTCH1 gene, between May 2017 and July
2018 at the “Sapienza” University of Rome, Italy, in
order to assess the involvement of the ocular system in
this syndrome”.
All patients went through a complete ophthalmological
examination including history, best-corrected visual acu-
ity, intraocular pressure measurement using Goldmann
applanation tonometry after topical anesthetic drops ap-
plication, slit-lamp biomicroscopy, mydriatic indirect fun-
dus biomicroscopy and Spectral domain OCT.
OCT (Optical Coherence Tomography) is a non-
invasive, transpupillary and non-contact diagnostic im-
aging technique that uses the reflection of light signals
to obtain a considerable axial resolution of images. It is
capable of providing high resolution cross-sections of
the retina, optic nerve, vitreous and choroid. Patients
were imaged using the Spectral domain OCT (Spectralis
Family Acquisition Module, V5.1.3.0; Heidelberg Engin-
eering, Germany) with Heidelberg Eye Explorer (V
1.6.2.0), whose axial resolution was 3.5 μm and the trans-
verse resolution was approximately 15/20 μm, using both
the raster scan protocol (20°× 15°, 19 lines of scan) and
the radial scan protocol (20°, 6 lines of scan), centered
on the fovea. For every single radial protocol scan the
presence or absence of vitreoretinal interface pathologies
was evaluated to assess the presence of intraretinal and
subretinal fluid; in addition some retinal layers integrity,
such the external limiting membrane (ELM), the
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photoreceptor inner segment/outer segment (IS/OS)
junction layer and the inner limiting membrane (ILM),
was also evaluated.
We made the diagnosis of hypertelorism in accordance
with the Tassier classification [33].
When a patient was measured having interorbital dis-
tance greater than 30 mm, we consider that patient posi-
tive for hypertelorism without further grading of the
anomaly.
All patients went through an orthoptical examination
including abnormal head positions’ investigation, motor
function assessment using the Irvine test, to detect the
presence or absence of bifoveal fusion, manifest strabis-
mus as well as the diagnosis of deep amblyopia [34], the
cover and uncover test, the convergence test, and cor-
neal reflex evaluation.
We evaluated stereopsis, which is the perception of
depth and 3-dimensional structure obtained on the basis
of visual information deriving from two eyes, using the
Lang test.
Strabismus is defined as a deviation of the primary lines
of sight of 1 prism diopter (PD) or more. In strabismus,
one eye is either constantly or intermittently not directed
toward the same point as the other eye when the patient
attempts to fixate an object. As a result, an image of the
fixated object is not formed on the fovea of the strabismic
eye. The convergent (inward) misalignment of one eye is
defined as esotropia; a divergent (outward) misalignment,
exotropia; an upward misalignment, hypertropia; a down-
ward misalignment, hypotropia [35].
Results
Eleven subjects, 7 females and 4 males, with diagnosis of
Gorlin-Goltz syndrome were recruited Table 1.
Nine patients (82%) were affected by various degrees
of myopia from − 0.5 to − 10 D.
Myopia is an ocular disorder in which the optical
power of the eye is too strong for the corresponding
axial length. Light rays from an object at infinity enter-
ing a non-accommodating myopic eye are converged too
strongly and focus in front of the retina. Two patients
(18%) showed a high anisometropia, a particular condi-
tion characterized by a different refractive power be-
tween the eyes, specifically 6 diopters difference in one
patient, and 10 diopters difference in the other, two pa-
tients (18%) were emmetropes.
Seven patients (63%) presented different types of stra-
bismus with absence of stereopsis: two patients showed
esotropia associated with a vertical deviation (V pattern),
one patient presented an exotropia associated with verti-
cal deviation (V pattern) and one patient presented only
with vertical deviation for inferior oblique overaction.
Two other patients were presented with intermittent
esophoria/tropia: inward deviation of the eye, usually
due to extra-ocular muscle imbalance. The esotropia
present in our sample ranged from 6 to 12 prismatic di-
opters while the exotropia from 10 to 14 prismatic diop-
ters. None of these patients presented diplopia, also
known as double vision.
Five patients (45,5%) presented with hypertelorism.
Slit-lamp examination revealed congenital cataract,
which is an opacity of the lens present at birth in two
patients, (one associated with a reduction in visual acuity
(5/10) while the other with a conserved visual acuity).
One patient presented with posterior subcapsular cata-
ract in the left eye while another patient presented with
bilateral pseudophakia.
One patient was affected by glaucoma with intraocular
pressure well controlled by topical pharmacological
treatment.
Fundus examination highlighted myelinated optic
nerve fiber layers in four of our patients (36%), vitreoret-
inal interface pathologies in four patients (36%) and
coloboma of the optic nerve in one of the patients
(9%)(Fig. 1). In particular the vitreoretinal interface path-
ologies that were observed in four of our patients exhib-
ited different patterns: three eyes presented a retraction
of the inner limiting membrane (ILM), a thin and avas-
cular membrane which separates the vitreous body from
the retina and plays a role in the pathophysiology of
some vitreomacular interface disorders [36], with a pre-
served visual acuity of 10/10, while two eyes were char-
acterized by a macular pucker (a scar tissue that has
formed on the macula and caused wrinkles, creases or
bulges to change the flat topography of the macula, ne-
cessary for it to function properly), responsible for a re-
duction in visual acuity (respectively 1/10 and 5/10).
Discussion
The ocular system has been poorly investigated in
Gorlin-Goltz syndrome: our study demonstrates that it
is frequently affected and that the main ophthalmo-
logical manifestations are myopia, strabismus, myelin-
ated optic nerve fiber layers and hypertelorism. Given
that our sample size for the purpose of most relevant
statistical analysis falls short, we decided to report only
the percentage of patients affected by a certain pathology
out of the whole group. Further research in larger
groups of patients is needed to determine whether these
rates are somewhat accurate.
Myopia is classified into two groups: non-pathologic
and pathologic myopia. In non-pathologic myopia the
refractive structures of the eye develop within normal
limits, however the refractive power of the eye does not
correlate with the axial length. The degree of non-
pathologic myopia is usually minimal to moderate (<
6.00 diopters) and onset usually begins during childhood
or adolescence. Pathologic myopia is classified as a high
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myopic refractive error that is progressive and pre-
sents early in childhood and is defined as spherical
equivalent > 6.00 diopters or axial length > 26.5 mm
[37]. Patients with high axial myopia are at a greater
risk of developing progressive retinal degeneration
and other vision threatening pathologies [38]. In our
patient population none of the subjects was affected
by pathological myopia.
It is important to underline that 73% of our patients
presented some pathologies (anisometropia, strabismus,
nystagmus) that can cause amblyopia, also known as
Lazy eye, which is the loss or lack of development of
central vision in one eye that is unrelated to an anatom-
ical problem and is not correctable with lenses. This is
consistent with Black et al. series (2003) [26]. It is crucial
to detect early these conditions during childhood in
order to treat them in time before they can determine
amblyopia, for once amblyopia is established, the eye or
both eyes involved present a definitive reduction of best-
corrected visual acuity.
Other ocular conditions requiring the involvement and
follow-up of an ophthalmologist in the management of
these patients are vitreoretinal alterations such as epiret-
inal membranes and macular puckers, for if not detected
and surgically treated, they can determine visual impair-
ment and progressive visual loss [39].
Interestingly the patients with GGS showing macular
puckers were younger than the average age of subjects
diagnosed with a macular pucker in the general popula-
tion [40]. Another interesting finding of the fundus
Fig. 1 Associations of ocular findings in the same patient
Fig. 2 Biomicroscopic photo of one of our patients presenting
coloboma of the optic nerve
Table 1 Ocular manifestations with their relative frequencies of
occurrence in our patients
Ocular manifestationts Gorlin-Goltz syndrome
Refractive Errors
Myopia 9/11 (82%)
Anisometropia 2/11 (18%)
Emmetropia 2/11 (18%)
External examination
Strabismus 7/11 (63%)
Hypertelorism 5/11 (45,5%)
Nistagmus 1/11 (9%)
Palpebral ptosis 1/11 (9%)
Slit lamp examination
Cataract/Congenital opacity 2/11 (18%)
Fundus examination
Myelinated fibers 4/11 (36%)
Epiretinal membranes 4/11 (36%)
Coloboma of the optic nerve 1/11 (9%)
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examination was the frequent presence of myelinated
optic nerve fiber layers in these subjects: none of them
displayed any visual impairment due to this condition
and two of the patients showed both myelinated optic
nerve fiber layers and vitreoretinal interface abnormal-
ities. It could be interesting to study the association of
these two manifestations in order to understand if they
could have a diagnostic value if detected in the same eye
or the same patient.
Associations of ocular pathologies discovered in the
same patient (Fig. 2):
Two associations: Three patients presented with stra-
bismus and cataract. Two patients showed macular
pucker and myelinated fibers (Fig. 3). Two patients pre-
sented strabismus and anisometropia.
Three associations: Two patients showed strabismus,
cataract and macular pucker.
Two patients showed strabismus, hypertelorism and
myelinated optic fibers.
Four associations: One patient showed strabismus,
macular pucker, hypertelorism. and coloboma of the
optic nerve (Fig. 4).
Five associations: One patient presented with strabis-
mus, macular pucker, hypertelorism, cataract and mye-
linated optic nerve fiber layers.
Coloboma of the optic nerve is a finding that is ex-
tremely rare in the general population [41]. PTCH1 gene
plays a key role in embryogenesis, which may explain
this finding, although the exact mechanism by which this
manifestation occurs is unknown.
Fig. 3 SD-OCT scan showing myelinated optic nerve fiber layers and paramacular pucker in one of our patients with Gorlin syndrome
Fig. 4 Hypertelorism present in one of our patients
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Conclusions
Our data demonstrates that ocular involvement in
this syndrome is frequent and tends to concern re-
fractive errors and ocular motility disorders. Some
ocular pathologies found in this group of patients,
such as macular pucker, coloboma of the optic nerve,
congenital cataract and strabismus can cause visual
acuity reduction and visual loss. Other manifestations
such as hypertelorism and myelinated optic nerve
fiber layers can be asymptomatic and do not deter-
mine any visual acuity reduction.
Because of the high rate of presentation of the follow-
ing pathologies in our group of patients, we suggest that
the presence of strabismus, myelinated optic nerve fiber
layers and/or vitreoretinal interface diseases in the same
subject suspected of being affected by the syndrome
could increase the suspicion and accelerate the diagnos-
tic process. This is particularly important where genetic
testing for this syndrome as a final confirmation of the
diagnosis is rarely used.
In conclusion, the study highlights the importance of
the ophthalmologist in managing patients with this rare
syndrome.
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